Cargando…
Hypomethylation of IL10 and IL13 Promoters in CD4(+) T Cells of Patients with Systemic Lupus Erythematosus
Interleukin- (IL-)10 and IL-13 play important roles in Th2 cell differentiation and production of autoantibodies in patients with (SLE). However, the mechanisms leading to IL10 and IL13 overexpression in SLE patients are not well understood. In this study, we confirm that the levels of both IL10 and...
Autores principales: | Zhao, Ming, Tang, Jinling, Gao, Fei, Wu, Xiaoyan, Liang, Yunsheng, Yin, Heng, Lu, Qianjin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879555/ https://www.ncbi.nlm.nih.gov/pubmed/20589076 http://dx.doi.org/10.1155/2010/931018 |
Ejemplares similares
-
IL-10 revisited in systemic lupus erythematosus
por: Biswas, Swayanka, et al.
Publicado: (2022) -
Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus
por: Godsell, Jack, et al.
Publicado: (2016) -
Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4(+) T cells in systemic lupus erythematosus
por: Liao, Wei, et al.
Publicado: (2017) -
Anti-IL-10 antibody in systemic lupus erythematosus
por: Uchida, Marina, et al.
Publicado: (2019) -
IL-10 promoter hypomethylation is associated with increased IL-10 expression and poor survival in hepatocellular carcinoma
por: Zhang, Xianjing, et al.
Publicado: (2019)